Chhabra, S., Searle, E., Popat, R., Magen, H., Gatt, M. E., Avivi, I., Baljevic, M., Korde, N., Valdes, C. R., Lichtman, E. I., Touzeau, C., Leleu, X. P., Svensson, A., Doerr, T., Yu, J., (Lee), X. (. L., Ahsan, A., Rosenberg, T., Talati, C., Kumar, S. (2026). Etentamig in patients (pts) with relapsed/refractory multiple myeloma (RRMM) with prior exposure to B-cell maturation antigen (BCMA)–targeted therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7508